You are here

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

 

Online download statistics by month:

Online download statistics by month: January 2022 to August 2025

AbstractFullPdf
Jan 2022542568251
Feb 2022252261123
Mar 2022145154122
Apr 202211512293
May 202212312698
Jun 2022141155108
Jul 2022143143111
Aug 202214414785
Sep 2022169170112
Oct 202219619893
Nov 202215415788
Dec 202215215258
Jan 202310910981
Feb 2023147153109
Mar 2023117118108
Apr 2023146147131
May 2023868754
Jun 202311711863
Jul 202310010169
Aug 202313313478
Sep 2023757643
Oct 2023787878
Nov 202313713864
Dec 202310210461
Jan 2024898950
Feb 202413313369
Mar 2024109112112
Apr 2024939258
May 2024868758
Jun 2024838557
Jul 202411011158
Aug 20248481195
Sep 202410910956
Oct 2024959765
Nov 202413113267
Dec 202413614294
Jan 2025798148
Feb 202511712270
Mar 2025747451
Apr 202512012361
May 2025747451
Jun 2025373730
Jul 2025110
Aug 2025110
Total538454993531